1. Home
  2. Labeler Index
  3. Astrazeneca Pharmaceuticals Lp
  4. 0310-3000
  5. NDC Package Code: 0310-3000-10 Anifrolumab

NDC Package 0310-3000-10 Anifrolumab

Solution - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0310-3000-10
Package Description:
11.7 kg in 1 POUCH
Product Code:
0310-3000
Non-Proprietary Name:
Anifrolumab
Substance Name:
Anifrolumab
11-Digit NDC Billing Format:
00310300010
Product Type:
Bulk Ingredient
Labeler Name:
Astrazeneca Pharmaceuticals Lp
Dosage Form:
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Active Ingredient(s):
  • ANIFROLUMAB 11.7 kg/11.7kg
    • Sample Package:
    N/A
    Marketing Category:
    BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
    Start Marketing Date:
    07-30-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0310-3000-10?

    The NDC Packaged Code 0310-3000-10 is assigned to an UNFINISHED drug package of 11.7 kg in 1 pouch of Anifrolumab, a bulk ingredient labeled by Astrazeneca Pharmaceuticals Lp. The product's dosage form is solution and is administered via form.

    Is NDC 0310-3000 included in the NDC Directory?

    Yes, Anifrolumab is an UNFINISHED PRODUCT with code 0310-3000 that is active and included in the NDC Directory. The product was first marketed by Astrazeneca Pharmaceuticals Lp on July 30, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0310-3000-10?

    The 11-digit format is 00310300010. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20310-3000-105-4-200310-3000-10